These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 34517057

  • 1. Tumor-targeted hyaluronic acid-mPEG modified nanostructured lipid carriers for cantharidin delivery: An in vivo and in vitro study.
    Sun S, Shang E, Ju A, Li Y, Wu Q, Li Q, Yang Y, Guo Y, Yang D, Lv S.
    Fitoterapia; 2021 Nov; 155():105033. PubMed ID: 34517057
    [Abstract] [Full Text] [Related]

  • 2. Enhanced anticancer efficacy of cantharidin by mPEG-PLGA micellar encapsulation: An effective strategy for application of a poisonous traditional Chinese medicine.
    Yao H, Zhao J, Wang Z, Lv J, Du G, Jin Y, Zhang Y, Song S, Han G.
    Colloids Surf B Biointerfaces; 2020 Dec; 196():111285. PubMed ID: 32771818
    [Abstract] [Full Text] [Related]

  • 3. Hyaluronic acid derivative-modified nano-structured lipid carrier for cancer targeting and therapy.
    Liu X, Liu H, Wang SL, Liu JW.
    J Zhejiang Univ Sci B; 2020 Jul; 21(7):571-580. PubMed ID: 32633111
    [Abstract] [Full Text] [Related]

  • 4. Engineering of lipid prodrug-based, hyaluronic acid-decorated nanostructured lipid carriers platform for 5-fluorouracil and cisplatin combination gastric cancer therapy.
    Qu CY, Zhou M, Chen YW, Chen MM, Shen F, Xu LM.
    Int J Nanomedicine; 2015 Jul; 10():3911-20. PubMed ID: 26089667
    [Abstract] [Full Text] [Related]

  • 5. Surface engineered nanostructured lipid carriers for targeting MDR tumor: Part II. In vivo biodistribution, pharmacodynamic and hematological toxicity studies.
    Negi LM, Talegaonkar S, Jaggi M, Verma AK, Verma R, Dobhal S, Kumar V.
    Colloids Surf B Biointerfaces; 2014 Nov 01; 123():610-5. PubMed ID: 25454755
    [Abstract] [Full Text] [Related]

  • 6. Redox-sensitive and hyaluronic acid functionalized liposomes for cytoplasmic drug delivery to osteosarcoma in animal models.
    Chi Y, Yin X, Sun K, Feng S, Liu J, Chen D, Guo C, Wu Z.
    J Control Release; 2017 Sep 10; 261():113-125. PubMed ID: 28666726
    [Abstract] [Full Text] [Related]

  • 7. Hyaluronic acid-coated nanostructured lipid carriers for targeting paclitaxel to cancer.
    Yang XY, Li YX, Li M, Zhang L, Feng LX, Zhang N.
    Cancer Lett; 2013 Jul 01; 334(2):338-45. PubMed ID: 22776563
    [Abstract] [Full Text] [Related]

  • 8. Lung cancer gene therapy: Transferrin and hyaluronic acid dual ligand-decorated novel lipid carriers for targeted gene delivery.
    Zhang B, Zhang Y, Yu D.
    Oncol Rep; 2017 Feb 01; 37(2):937-944. PubMed ID: 27959442
    [Abstract] [Full Text] [Related]

  • 9. Development of 11-DGA-3-O-Gal-Modified Cantharidin Liposomes for Treatment of Hepatocellular Carcinoma.
    Zhou L, Zou M, Zhu K, Ning S, Xia X.
    Molecules; 2019 Aug 24; 24(17):. PubMed ID: 31450608
    [Abstract] [Full Text] [Related]

  • 10. Development of Glycyrrhetinic Acid and Folate Modified Cantharidin Loaded Solid Lipid Nanoparticles for Targeting Hepatocellular Carcinoma.
    Xu Y, Wang M, Ning S, Yang Z, Zhou L, Xia X.
    Molecules; 2022 Oct 11; 27(20):. PubMed ID: 36296377
    [Abstract] [Full Text] [Related]

  • 11. Co-delivery of baicalein and doxorubicin by hyaluronic acid decorated nanostructured lipid carriers for breast cancer therapy.
    Liu Q, Li J, Pu G, Zhang F, Liu H, Zhang Y.
    Drug Deliv; 2016 May 11; 23(4):1364-8. PubMed ID: 25874959
    [Abstract] [Full Text] [Related]

  • 12. Hyaluronic acid modified nanostructured lipid carriers for transdermal bupivacaine delivery: In vitro and in vivo anesthesia evaluation.
    Yue Y, Zhao D, Yin Q.
    Biomed Pharmacother; 2018 Feb 11; 98():813-820. PubMed ID: 29571251
    [Abstract] [Full Text] [Related]

  • 13. Hyaluronic acid-coated nanostructured lipid carriers for loading multiple traditional Chinese medicine components for liver cancer treatment.
    Sun S, Guan Q, Shang E, Xiao H, Yu X, Shi L, Zhao C, Guo Y, Lv S, Li Y.
    Pak J Pharm Sci; 2020 Jan 11; 33(1):109-119. PubMed ID: 32122838
    [Abstract] [Full Text] [Related]

  • 14. Effect of octreotide-polyethylene glycol(100) monostearate modification on the pharmacokinetics and cellular uptake of nanostructured lipid carrier loaded with hydroxycamptothecine.
    Su Z, Niu J, Xiao Y, Ping Q, Sun M, Huang A, You W, Sang X, Yuan D.
    Mol Pharm; 2011 Oct 03; 8(5):1641-51. PubMed ID: 21770405
    [Abstract] [Full Text] [Related]

  • 15. Integrating the drug, disulfiram into the vitamin E-TPGS-modified PEGylated nanostructured lipid carriers to synergize its repurposing for anti-cancer therapy of solid tumors.
    Banerjee P, Geng T, Mahanty A, Li T, Zong L, Wang B.
    Int J Pharm; 2019 Feb 25; 557():374-389. PubMed ID: 30610896
    [Abstract] [Full Text] [Related]

  • 16. Preparation and evaluation of PEGylated asiatic acid nanostructured lipid carriers on anti-fibrosis effects.
    Chen X, Zhang Y, Zhao P, Chen Y, Zhou Y, Wang S, Yin L.
    Drug Dev Ind Pharm; 2020 Jan 25; 46(1):57-69. PubMed ID: 31813288
    [Abstract] [Full Text] [Related]

  • 17. Surface engineered nanostructured lipid carriers for targeting MDR tumor: Part I. Synthesis, characterization and in vitro investigation.
    Negi LM, Talegaonkar S, Jaggi M, Verma AK, Verma R, Dobhal S, Kumar V.
    Colloids Surf B Biointerfaces; 2014 Nov 01; 123():600-9. PubMed ID: 25454761
    [Abstract] [Full Text] [Related]

  • 18. Hyaluronic acid-coated, prodrug-based nanostructured lipid carriers for enhanced pancreatic cancer therapy.
    Lu Z, Su J, Li Z, Zhan Y, Ye D.
    Drug Dev Ind Pharm; 2017 Jan 01; 43(1):160-170. PubMed ID: 27553814
    [Abstract] [Full Text] [Related]

  • 19. Dimeric c(RGD) peptide conjugated nanostructured lipid carriers for efficient delivery of Gambogic acid to breast cancer.
    Kebebe D, Wu Y, Zhang B, Yang J, Liu Y, Li X, Ma Z, Lu P, Liu Z, Li J.
    Int J Nanomedicine; 2019 Jan 01; 14():6179-6195. PubMed ID: 31447559
    [Abstract] [Full Text] [Related]

  • 20. Optimization, stabilization, and characterization of amphotericin B loaded nanostructured lipid carriers for ocular drug delivery.
    Lakhani P, Patil A, Wu KW, Sweeney C, Tripathi S, Avula B, Taskar P, Khan S, Majumdar S.
    Int J Pharm; 2019 Dec 15; 572():118771. PubMed ID: 31669555
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.